Machinery & Materials
Logistics & Cold Chain
More from Acumen Fund
Acumen Fund Invests in Sproxil, Inc. to Combat Counterfeit Medicine Using Mobile Technology
Acumen Fund, a nonprofit global venture fund addressing poverty in South Asia and East Africa, today announced an investment in Sproxil, Inc., a company that provides a Mobile Product Authentication (MPA) solution that enables consumers to verify that the pharmaceutical product they are buying is genuine.
Mar 28th, 2011